Zobrazeno 1 - 10
of 53
pro vyhledávání: '"D. V. Ivashchenko"'
Autor:
D. V. Ivashchenko, N. I. Buromskaya, A. D. Malakhova, N. A. Tsarkova, L. M. Savchenko, Yu. S. Shevchenko, D. A. Sychev
Publikováno v:
Неврология, нейропсихиатрия, психосоматика, Vol 13, Iss 3, Pp 19-26 (2021)
Antipsychotics are often used to treat children and adolescents. Because of their age, there are a lot of off-label prescribed antipsychotics in that population. However, the off-label use of medications is considered to be potentially unsafe.Objecti
Externí odkaz:
https://doaj.org/article/359a8e7c61d34ad69413c10b1227e37c
Autor:
D. V. Ivashchenko, A. S. Osipov, E. V. Nazarova, M. A. Ovchinnikova, N. I. Buromskaya, V. V. Smirnov, P. V. Shimanov, R. V. Deitch, T. A. Fainshtein, E. N. Shagovenko, K. A. Akmalova, A. A. Kachanova, E. A. Grishina, L. M. Savchenko, Yu. S. Shevchenko, D. A. Sychev
Publikováno v:
Неврология, нейропсихиатрия, психосоматика, Vol 12, Iss 6, Pp 11-18 (2020)
Antipsychotics are a first-line treatment for psychotic disorders. The cytochrome P450 isoenzymes CYP3A4/5 and CYP2D6 metabolize most antipsychotics. The activity of these isoenzymes in children changes with maturation, so it is different from that i
Externí odkaz:
https://doaj.org/article/cb134be0ac0d48f88a599fa1d86958d4
Autor:
K. B. Mirzaev, D. V. Ivashchenko, I. V. Volodin, E. A. Grishina, K. A. Akmalova, A. A. Kachanova, A. I. Skripka, R. M. Minnigulov, T. E. Morozova, O. A. Baturina, A. N. Levanov, T. V. Shelekhova, A. I. Kalinkin, D. A. Napalkov, A. A. Sokolova, D. A. Andreev, I. N. Sychev, P. O. Bochkov, D. A. Sychev
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 16, Iss 5, Pp 670-677 (2020)
Aim. To search for new pharmacogenetic biomarkers of bleeding risk in patients taking rivaroxaban and dabigatran for different indications: atrial fibrillation, endoprosthesis of large joints of lower limbs.Material and methods. The study enrolled 29
Externí odkaz:
https://doaj.org/article/060e30356f7741b38e1ef181c3cd5e48
Autor:
Yu. Yu. Kiselev, K. A. Zagorodnikova, D. V. Ivashchenko, A. V. Krykov, I. N. Sychev, A. S. Matveev, K. B. Mirzaev, V. A. Otdelenov, V. M. Tsvetov, A. V. Dmitriev, V. V. Poroikov, D. A. Sychev
Publikováno v:
Качественная клиническая практика, Vol 0, Iss 4S, Pp 75-80 (2020)
At the time of print, the evidence for using umifenovir in COVID-19 is mainly theoretical. The published clinical trials have contradicting results. The decision to use umifenovir in COVID-19 should be individualized, considering the “experimental
Externí odkaz:
https://doaj.org/article/086bc563d1bf4e7db1fc4d0bf2b37ae3
Autor:
D. V. Ivashchenko, S. Z. Khoang, M. Kh. Tazagulova, B. V. Makhmudova, N. I. Buromskaya, P. V. Shimanov, R. V. Deitch, I. V. Dorina, M. I. Nastovich, K. A. Akmalova, A. A. Kachanova, E. A. Grishina, L. M. Savchenko, Yu. S. Shevchenko, D. A. Sychev
Publikováno v:
Неврология, нейропсихиатрия, психосоматика, Vol 12, Iss 5, Pp 24-31 (2020)
Children and adolescents are more likely than adults to experience adverse side effects when taking antipsychotics. Pharmacogenetic testing allows one to more accurately choose the initial dose of a drug. The genes of pharmacokinetic factors have bee
Externí odkaz:
https://doaj.org/article/7997357ca57c4d20be84eae91f17b21f
Autor:
D. V. Ivashchenko, O. V. Tereshchenko, I. I. Temirbulatov, K. A. Akmalova, E. A. Grishina, M. S. Zastrozhin, L. M. Savchenko, E. A. Bryun, D. A. Sychev
Publikováno v:
Неврология, нейропсихиатрия, психосоматика, Vol 12, Iss 2, Pp 17-22 (2020)
Phenazepam is a benzodiazepine tranquilizer that is widely used in Russia. The drug is metabolized by cytochrome P450 3A (CYP3A) isozymes. Since their substrates have an affinity for P-glycoprotein, the polymorphic variants in the ABCB1 gene may affe
Externí odkaz:
https://doaj.org/article/9d0c6b0bd07445248026e3297ae469d4
Autor:
D. V. Ivashchenko, N. I. Buromskaya, P. V. Shimanov, D. V. Deitch., K. A. Ryzhykova, Е. A. Grishina, Yu. S. Shevchenko, D. A. Sychev
Publikováno v:
Обозрение психиатрии и медицинской психологии имени В.М. Бехтерева, Vol 0, Iss 4-1, Pp 75-77 (2019)
Currently, there is a lack of pharmacogenetic research of antipsychotics’ safety in children and adolescents with acute psychotic episodes. Genetic polymorphisms of CYP2D6 and ABCB1 are the most likely candidates for such studies. AIM.To establish
Externí odkaz:
https://doaj.org/article/08ac661ad8a8481ba7f50dd5e1168baa
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 15, Iss 3, Pp 393-406 (2019)
Aim. To summarize Russian studies using pharmacogenetic testing as applied to cardiology.Material and methods. The authors conducted an online search for articles in December 2018 using the following databases: PubMed, Google Scholar, eLIBRARY. The s
Externí odkaz:
https://doaj.org/article/684bcc0fe94c4fb6b703cc888c641692
Autor:
E. S. Ilina, V. A. Shalygin, D. V. Ivashchenko, M. I. Savelieva, I. I. Sinitsina, S. P. Semenova, S. V. Gorbatenkova, S. N. Puzin, O. T. Bogova, D. A. Sychev
Publikováno v:
Нервно-мышечные болезни, Vol 9, Iss 1, Pp 67-74 (2019)
The article discusses aspects of drug-induced falls in elderly comorbid patients against the background of polypragmasy and also assesses the role of drug interactions that are highly dangerous according to the risk of falling. A drug audit of the ob
Externí odkaz:
https://doaj.org/article/05c467a805594dce93dec57fc1cb0d6b
Publikováno v:
Неврология, нейропсихиатрия, психосоматика, Vol 11, Iss 1, Pp 89-95 (2019)
Deprescribing is the opposite of prescribing drugs, the purpose of which is to improve quality of life and reduce the risk of adverse drug reactions. The paper considers the process of deprescribing benzodiazepines. It analyzes relevant studies on th
Externí odkaz:
https://doaj.org/article/4c2f4db116f34c01b9f98aaba02f86a2